Systemic Lupus Erythematosus - Pharma

Relevant Publications

Lupus erythematosus-specific bullous lesions.

Issue Release: 2026

Immune-mediated inflammatory diseases and periodontal disease: a bidirectional two-sample mendelian randomization study.

Issue Release: 2024

Symmetric leukoencephalopathy associated with systemic lupus erythematosus: A systematic review of a distinctive neurorheumatologic syndrome.

Issue Release: 2024

Frequency and predictors for early-achieved lupus low disease activity state in systemic lupus erythematosus patients treated with telitacicept or belimumab: A real-life, single-center observational study.

Issue Release: 2024

Kidney transplantation from a systemic lupus erythematosus donor and 1-year follow-up: A case report.

Issue Release: 2024

Is systemic lupus erythematosus linked to Immunoglobulin G4 Autoantibodies?

Issue Release: 2024

Therapy with regulatory T-cell infusion in autoimmune diseases and organ transplantation: A review of the strengths and limitations.

Issue Release: 2024

Evaluation of walking activity and gait to identify physical and mental fatigue in neurodegenerative and immune disorders: preliminary insights from the IDEA-FAST feasibility study.

Issue Release: 2024

The PP2A Inhibitor LB-100 Mitigates Lupus Nephritis by Suppressing Tertiary Lymphoid Structure Formation.

Issue Release: 2024

Association of sustained lupus low disease activity state with improved outcomes in systemic lupus erythematosus: a multinational prospective cohort study.

Issue Release: 2024

Clinical management of lupus in the United States: A claims-based analysis.

Issue Release: 2024

Modifying T cell phenotypes using TYK2 inhibitor and its implications for the treatment of systemic lupus erythematosus.

Issue Release: 2024

Digital ischemic necrosis in a patient with systematic lupus erythematosus patient after severe acute respiratory syndrome coronavirus 2 infection: a case report.

Issue Release: 2024

Efficacy and safety of telitacicept therapy in systemic lupus erythematosus with hematological involvement.

Issue Release: 2024

Clinical disease activity in autoimmune rheumatic patients receiving COVID-19 vaccines.

Issue Release: 2024

Hirsutella sinensis polysaccharides and Parabacteroides goldsteinii reduce lupus severity in imiquimod-treated mice.

Issue Release: 2024

Differential lncRNA profiles of blood plasma-derived exosomes from systemic lupus erythematosus.

Issue Release: 2024

Generation of a competing endogenous RNA network and validation of BNIP1 expression in the lung of irradiated mice.

Issue Release: 2024

Value of SLE-DAS in assessing disease activity in patients with systemic lupus erythematosus: a single-centre retrospective study.

Issue Release: 2024

Fatigue and sleep quality in Chinese adults with connective tissue disease: A cross-sectional study.

Issue Release: 2024

What Challenges Exist in Patient Education?

What is Patient Education in Pharma?

Why are Collaborative Care Models Important in Pharma?

What are the Challenges in Implementing Collaborative Care Models?

What Roles Do Pharmacists Play in Pharma?

What are the Key Cellular Stress Pathways?

Why is Geriatric Care Important?

What are Chronic Conditions?

How Long Does the Approval Process Take?

What are Contract Research Organizations (CROs)?

Partnered Content Networks

Relevant Topics